The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HB-200 arenavirus-based immunotherapy plus pembrolizumab as first-line treatment of patients with recurrent/metastatic HPV16-positive head and neck cancer: Updated results.
 
Alan Loh Ho
Stock and Other Ownership Interests - Rgenta
Honoraria - Chinese American Hematology and Oncology Network; Endocrine Society (Clinical Endocrinology Update); Physicans' Education Resource
Consulting or Advisory Role - AffyImmune Therapeutics; Cellestia Biotech; Coherus Biosciences; Eisai; Eisai; Elevar Therapeutics; Exelixis; ExpertConnect; InxMed; Kura Oncology; Merck; Nested Therapeutics; Prelude Therapeutics; Remix Therapeutics; Rgenta
Research Funding - Astellas Pharma; AstraZeneca; Ayala Pharmaceuticals; Bayer; Bayer; BioAtla; Bristol-Myers Squibb; Eisai; Elevar Therapeutics; Elevar Therapeutics; Genentech/Roche; Kura Oncology; Merck; Novartis; OncC4; Poseida; TILT Biotherapeutics; Verastem
Patents, Royalties, Other Intellectual Property - LESIONAL DOSIMETRY METHODS FOR TAILORING TARGETED RADIOTHERAPY IN
 
Lisle Nabell
No Relationships to Disclose
 
Prakash C. Neupane
Honoraria - Merck
Research Funding - Merck Sharp & Dohme
 
Marshall R. Posner
Honoraria - Naveris
Consulting or Advisory Role - Aveo; Calliditas Therapeutics; Galeria; Merck; Merus
Research Funding - BioNTech (Inst); Flamingo Pharma (Inst); Gilead Sciences (Inst); Hookipa Pharma (Inst); ISA Pharmaceuticals (Inst); Regeneron (Inst); Toragen (Inst)
Patents, Royalties, Other Intellectual Property - anti-Staphylococcal Monoclonal antibody (Inst); Uptodate editor
(OPTIONAL) Uncompensated Relationships - Frizent; Vivan Therapeutics
 
Emrullah Yilmaz
Consulting or Advisory Role - Astellas Pharma
 
Jiaxin Niu
Consulting or Advisory Role - AstraZeneca; Bristol Mers Squibb; Daiichi Sankyo; G1 Therapeutics; Johnson & Johnson; Mirati Therapeutics; Pfizer; Sanofi; Takeda
 
Abdul Rafeh Naqash
Honoraria - NGM Biopharmaceuticals
Consulting or Advisory Role - foundation me
Travel, Accommodations, Expenses - American Society for Radiation Oncology; ASCO; Binacea; Foundation Medicine; Jazz Pharmaceuticals (Inst); Society for Immunotherapy of Cancer
 
Alexander T. Pearson
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Abbvie; Ayala Pharmaceuticals; Elevar Therapeutics; Prelude Therapeutics
Research Funding - Abbvie (Inst); EMD Serono (Inst); Kura Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
Stuart J. Wong
Research Funding - Hookipa Pharma; Merck; Novartis
 
Jorge J. Nieva
Stock and Other Ownership Interests - Cansera; Epic Sciences; Indee P/L
Consulting or Advisory Role - AADi; ANP Technologies; AstraZeneca; Bioatla; Mindmed
Research Funding - Genentech (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending - movement and unexpected healthcare encounters
 
Douglas Earl Laux
Research Funding - Hookipa Pharma
 
Deborah J.L. Wong
Consulting or Advisory Role - Merck; Regeneron
Research Funding - ARMO BioSciences (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bicara Therapeutics (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); Elevar Therapeutics (Inst); Enzychem Lifesciences (Inst); Flamingo Pharma (Inst); FSTAR (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Hookipa Biotech (Inst); Kura Oncology (Inst); Lilly; Lilly (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Regeneron (Inst); TopAlliance BioSciences Inc (Inst)
 
Zujun Li
Stock and Other Ownership Interests - CVS
Honoraria - AstraZeneca; Coherus BioSciences
Consulting or Advisory Role - AstraZeneca; Coherus BioSciences
Speakers' Bureau - Coherus BioSciences
Travel, Accommodations, Expenses - Coherus BioSciences
 
Ari Joseph Rosenberg
Stock and Other Ownership Interests - Galectin Therapeutics; Privo Technologies
Consulting or Advisory Role - Astellas Pharma; Eisai; EMD Serono; Nanobiotix; Novartis; Regeneron; Vaccitech
Speakers' Bureau - Coherus Biosciences
Research Funding - Abbvie (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene (Inst); EMD Serono (Inst); Hookipa Biotech (Inst); Purple Biotech (Inst)
 
Winston Wong
Research Funding - BioAtla
 
Xiaoping Qing
Employment - Hookipa Pharma
Stock and Other Ownership Interests - Hookipa Pharma
 
Corinne Iacobucci
Employment - Hookipa Pharma
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Henning Lauterbach
Employment - Biogen (I); Hookipa Pharma
Stock and Other Ownership Interests - Biogen (I); BioNTech SE; Hookipa Pharma; TScan Therapeutics
Patents, Royalties, Other Intellectual Property - Inventor on patents and patent applications from Hookipa Pharma
 
Ilian Tchakov
Employment - Hookipa Biotech
Stock and Other Ownership Interests - Hookipa Biotech
 
David G. Pfister
Consulting or Advisory Role - MeiraGTx; Nykode Therapeutics
Research Funding - Akeso Biopharma; AstraZeneca (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Eisai (Inst); Hookipa Pharma (Inst); Lilly (Inst); MedImmune (Inst); MeiraGTx (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)